Skip to main content
Log in

Inhibitory effect of Shenqi Fuzheng injection combined with docetaxel on lung cancer cells

参芪扶正注射液与多西他赛联用对肺癌细胞抑制作用的初步研究

  • Correspondence
  • Published:
Journal of Zhejiang University-SCIENCE B Aims and scope Submit manuscript

概要

目 的

研究参芪扶正注射液配伍多西他赛后对肺癌细胞A549 和LLC 生长的抑制作用。

创新点

首次发现参芪扶正注射液配伍多西他赛后能提高低浓度多西他赛对肺癌细胞的生长抑制率, 且对不同肺癌细胞的抑制率有不同的增强作用。

方 法

对A549 及LLC 细胞均设置参芪扶正注射液五个浓度单独给药、多西他赛九个浓度单独给药、参芪扶正注射液两个浓度分别联合多西他赛五个浓度给药三组。使用MTT 比色法考察不同给药组对于肺癌细胞的生长抑制率, 并对比多西他赛单独与联用后对细胞生长的抑制率。

结 论

实验结果显示参芪扶正注射液单独使用对于两种肺癌细胞均无明显抑制作用, 但是联合使用对多西他赛抗肿瘤作用有明显的增强效果。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Bruno, R., Hille, D., Riva, A., et al., 1998. Population pharmacokinetics/ pharmacodynamics of docetaxel in phase II studies in patients with cancer. J. Clin. Oncol., 16(1):187–196. http://dx.doi.org/10.1200/JCO.1998.16.1.187

    CAS  PubMed  Google Scholar 

  • Granville, C.A., Dennis, P.A., 2005. An overview of lung cancer genomics and proteomics. Am. J. Respir. Cell Mol. Biol., 32(3):169–176. http://dx.doi.org/10.1165/rcmb.F290

    Article  CAS  PubMed  Google Scholar 

  • Kong, T.D., Liu, D.N., Gao, W.Y., et al., 2014. Effect of Shenqi Fuzheng injection on immune function and quality of life in advanced non-small cell lung cancer patients with palliative treatment. China J. Chin. Med., 29(8):1097–1098 (in Chinese).

    Google Scholar 

  • Saloustros, E., Mavroudis, D., Georgoulias, V., 2008. Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin. Phamacother., 9(15):2603–2616. http://dx.doi.org/10.1517/14656566.9.15.2603

    Article  CAS  Google Scholar 

  • Stewart, B.W., Wild, C.P., 2014. The global and regional burden of cancer. In: World Cancer Report 2014. World Health Organization, p.16–54.

    Google Scholar 

  • Zhang, W.Y., Zhang, W.M., Wang, L., et al., 2011. Sequence-dependent effect of docetaxel with gefitinib on the proliferation and signal protein expression of human lung adenocarcinoma cell SPC-A1. China J. Lung Cancer, 14(5):385–390 (in Chinese). http://dx.doi.org/10.3779/j.issn.1009-3419.2011.05.01

    Google Scholar 

  • Zhong, M.W., Li, Q.Z., Ye, H.Q., et al., 2015. Clinical observation of shenqi fuzheng injection combing docetaxel and lobaplatin in treatment of old middle-advanced stage lung cancer. Clin. J. Tradit. Chin. Med., 27(5):676–679 (in Chinese). http://dx.doi.org/10.16448/j.cjtcm.2015.0257

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yang Lu or Shou-ying Du.

Additional information

Project supported by the Beijing Science and Technology Star Project (No. xx2015A048), China

ORCID: Bo-yu DONG, http://orcid.org/0000-0002-3415-9090

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, By., Wang, C., Tan, L. et al. Inhibitory effect of Shenqi Fuzheng injection combined with docetaxel on lung cancer cells. J. Zhejiang Univ. Sci. B 18, 76–78 (2017). https://doi.org/10.1631/jzus.B1600357

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B1600357

关键词

Navigation